Francis Collins urges liver researchers to advocate for research
The American Association for the Study of Liver Diseases (AASLD) annual Liver Meeting is currently underway in Washington, D.C. The event brings together researchers, clinicians, and advocates in the field of hepatology to discuss the latest advancements in liver disease research and treatment. This year, the meeting is addressing some pressing issues facing the field, including the impact of federal research funding cuts and the looming challenges of the political landscape.
President Trump’s second term is casting a shadow over the gathering, with concerns about the politicization of scientific funding and research. Francis Collins, former NIH director, expressed his surprise at the partisan nature of scientific funding and highlighted the importance of advocating for science in the face of political challenges. Grace Li-Chun Su, the new president of AASLD, emphasized the need for researchers and clinicians to advocate for the future of hepatology and to engage in public health policy discussions.
Senator Bill Cassidy of Louisiana made a surprise appearance at the meeting, discussing important issues such as expanding access to hepatitis C treatments and the impact of the government shutdown on healthcare initiatives. The shutdown has also affected some attendees’ travel plans, showcasing the widespread impact of political decisions on scientific conferences and research activities.
In addition to political challenges, the meeting is also addressing important research findings in the field of hepatology. Studies presented at the meeting are shedding light on new approaches to liver disease treatment, including the use of statins for cirrhosis patients and supplemental feeding for patients with decompensated cirrhosis. Other studies are challenging traditional paradigms of liver disease treatment, such as the use of oral betaine as an antioxidant and the evaluation of noninvasive tests for liver disease screening.
The meeting is also highlighting the growing overlap between hepatology and addiction medicine, with clinicians incorporating techniques from psychology and psychiatry into their practice. Motivational interviewing and other psychological interventions are being used to help patients with alcohol use disorder and obesity-related liver diseases.
Overall, the Liver Meeting is providing a platform for researchers, clinicians, and advocates to come together and discuss the latest advancements and challenges in the field of hepatology. By addressing political, scientific, and clinical issues, the meeting is shaping the future of liver disease research and treatment. The liver health conference this year had some interesting insights and events that took place, with the lead author Ge mentioning that the tool being discussed needs more work before it can be widely used. According to Ge, the tool may be suitable for low-complexity cases, but it still requires refinement for mainstream use.
One standout moment at the conference was the presentation by UCSF hepatologist Jennifer Lai, who emphasized the importance of embracing advancements in liver health care. Lai expressed that the evolution towards more advanced liver health treatments is inevitable and presents a significant opportunity for national societies to enhance patient care.
A unique feature of this year’s conference was an indoor “park” spanning two floors, offering attendees a chance to unwind and engage in recreational activities. From pickleball courts to a golf simulator and a giant chessboard, there was no shortage of entertainment options for conference-goers to enjoy during their breaks.
The conference hall was also filled with marketing displays from sponsors, with Novo Nordisk’s Wegovy advertisement catching the eye of many attendees. The message seemed to resonate well, as prescribing information pamphlets at the base of the escalators quickly disappeared.
In addition to sponsor displays, evening events sponsored by companies like Boehringer Ingelheim and Gilead Sciences provided networking opportunities for attendees. A Pride reception on Saturday night was a highlight, offering a chance for attendees to socialize and unwind after a day of scientific sessions.
One of the most memorable moments at the conference was the appearance of Livvy the Liver, the mascot of the Liver Education Advocates. Livvy’s presence created a buzz in the main hall, with attendees lining up to take photos with the detox diva. Livvy’s mission to raise awareness for liver health and nonalcoholic fatty liver disease was well-received by conference-goers.
As the conference continues, attendees can look forward to more exciting scientific presentations and discussions. Stay tuned for updates on the latest liver health research and advancements. And if you’re wondering about that clinking sound from the event lanyards, rest assured that we’re working on a solution to minimize the noise.
